Larvol Delta - Efficacy-and-Safety-of-Glofitamab-in-the-RealWorld-Treatment-of-Patients-With-Primary-Refractory-or-Early-Relapsed-Diffuse-Large-BCell-Lymphoma

Columvi (glofitamab-gxbm) - Roche

https://www.chictr.org.cn/showproj.html?proj=308690

Sep 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next